Gastroesophageal Reflux Disease (GERD) Market to Expand at a Significant Growth Rate During the Forecast Period (2019-32) - Estimates DelveInsight

DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Gastroesophageal Reflux Disease Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Gastroesophageal Reflux Disease market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Gastroesophageal Reflux Disease (GERD): An Overview
Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder that occurs when acidic stomach juices or food and fluids back up from the stomach into the esophagus. GERD is the regular, persistent, and long-term occurrence of GER.

It is caused by multiple different mechanisms that can be intrinsic, structural, or both, leading to the disruption of the esophagogastric junction barrier resulting in exposure of the esophagus to acidic gastric contents.

It is one of the most commonly diagnosed digestive disorders in the US with a prevalence of 20%, resulting in a significant economic burden in direct and indirect costs and adversely affecting the quality of life.

Gastroesophageal Reflux Disease (GERD) Market Key Facts
As per Jorabar Singh Nirwan et al (2020), the global pooled prevalence of GERD was 13.98%. Using the United Nations 2017 Revision of World Population Prospects, the estimated number of individuals suffering from GORD globally is 1.03 billion.
According to Marco G Patti (2020), 25%-40% of Americans experience symptomatic GERD at some point and about 7%-10% of Americans experience symptoms of GERD on a daily basis.
As per DelveInsight's assessment, GERD is more common in males than in females.
Some of the key companies in the Gastroesophageal Reflux Disease Market include Phathom Pharmaceutical, Takeda, Sinorda Biomedicine, and others.
The expected launch of the pipeline therapies such as Vanoprazan (Phathom Pharmaceuticals) and others is expected to transform the treatment scenario in the coming years.

Request a PDF sample copy of the report at:
https://www.delveinsight.com/sample-request/gastroesophageal-reflux-disease-gerd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gastroesophageal Reflux Disease (GERD) Market
As per DelveInsight, the Gastroesophageal Reflux Disease Therapeutics Market is expected to increase during the forecast period owing to the rise in the prevalent cases of GERD in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Gastroesophageal Reflux Disease market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Gastroesophageal Reflux Disease market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover more about the report offerings:
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gastroesophageal Reflux Disease (GERD) Epidemiology
The epidemiology section covers detailed insights into the historical and current Gastroesophageal Reflux Disease patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Gastroesophageal Reflux Disease (GERD) Epidemiology Segmentation
Diagnosed Cases of GERD
Prevalent Cases of GERD
Gender-specific Prevalent Cases of GERD
Age-specific Prevalent Cases of GERD
Treated Cases of GERD

Learn more about the Gastroesophageal Reflux Disease Epidemiology:
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gastroesophageal Reflux Disease (GERD) Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastroesophageal Reflux Disease market or expected to get launched in the market during the study period. The analysis covers Gastroesophageal Reflux Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Gastroesophageal Reflux Disease Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Get more detailed insights into the pipeline development activities:
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gastroesophageal Reflux Disease (GERD) Therapeutics Assessment
Gastroesophageal Reflux Disease (GERD) treatment aims to cut down on the amount of reflux or lessen damage to the lining of the esophagus from refluxed materials.

Currently, there are approx. 9+ key companies developing the therapies for Gastroesophageal Reflux Disease (GERD). Daewoong Pharmaceutical is leading the Gastroesophageal Reflux Disease (GERD) Therapeutics segment with its drug candidates in the most advanced stage, i.e. pre-registration phase.

Some of the key companies in the Gastroesophageal Reflux Disease Market include Daewoong Pharmaceutical, Phathom Pharmaceutical, Sinorda Biomedicine, Takeda, Cinclus Pharma, Jeil Pharmaceutical, Renexxion, Trio Medicines, Chong Kun Dang Pharmaceutical, HK inno.N Corporation, and several others.

The emerging therapies in the Gastroesophageal Reflux Disease Therapeutics Market include Vonoprazan, Renexxion, Fexuprazan, Naronapride, X842, JP-1366, AD-214, IN-C002, IN-C003, IN-C004, and many more.

Learn more about the emerging therapies & key companies: https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gastroesophageal Reflux Disease Report Key Insights
1. Gastroesophageal Reflux Disease Patient Population
2. Gastroesophageal Reflux Disease Market Size and Trends
3. Key Cross Competition in the Gastroesophageal Reflux Disease Market
4. Gastroesophageal Reflux Disease Market Dynamics (Key Drivers and Barriers)
5. Gastroesophageal Reflux Disease Market Opportunities
6. Gastroesophageal Reflux Disease Therapeutic Approaches
7. Gastroesophageal Reflux Disease Pipeline Analysis
8. Gastroesophageal Reflux Disease Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Gastroesophageal Reflux Disease Market

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Gastroesophageal Reflux Disease Competitive Intelligence Analysis
4. Gastroesophageal Reflux Disease Market Overview at a Glance
5. Gastroesophageal Reflux Disease Disease Background and Overview
6. Gastroesophageal Reflux Disease Patient Journey
7. Gastroesophageal Reflux Disease Epidemiology and Patient Population
8. Gastroesophageal Reflux Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Gastroesophageal Reflux Disease Unmet Needs
10. Key Endpoints of Gastroesophageal Reflux Disease Treatment
11. Gastroesophageal Reflux Disease Marketed Products
12. Gastroesophageal Reflux Disease Emerging Therapies
13. Gastroesophageal Reflux Disease Seven Major Market Analysis
14. Attribute Analysis
15. Gastroesophageal Reflux Disease Market Outlook (7 major markets)
16. Gastroesophageal Reflux Disease Access and Reimbursement Overview
17. KOL Views on the Gastroesophageal Reflux Disease Market.
18. Gastroesophageal Reflux Disease Market Drivers
19. Gastroesophageal Reflux Disease Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the report, at:
https://www.delveinsight.com/sample-request/gastroesophageal-reflux-disease-gerd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports as well as customized solutions to firms in the healthcare sector.

This release was published on openPR.